학술논문
925TiP - A phase 2 study of investigational TORC1/2 inhibitor TAK-228 and TAK-228 plus investigational PI3Kα-selective inhibitor TAK-117 vs everolimus in adults with advanced or metastatic clear-cell renal cell carcinoma (ccRCC) that has progressed on VEGF-targeted therapy
Document Type
Abstract
Author
Source
In Annals of Oncology September 2017 28 Supplement 5:v328-v328
Subject
Language
ISSN
0923-7534